FDA recall D-0435-2023

Sagent Pharmaceuticals Inc · Class II · drug

Product

Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01

Reason for recall

Labeling: Not elsewhere classified

Distribution

USA Nationwide

Key facts

Status
Completed
Initiation date
2023-02-28
Report date
2023-03-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
Schaumburg, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0435-2023